ESG resources

We report on a wide range of ESG data in our ESG Performance Report. We also report a number of additional disclosures below.

Latest reports

The ESG Performance Report includes our performance across our six environmental, social and governance (ESG) priority areas, and includes ESG data for current and previous years. Within the Responsible Business section of our Annual Report, we provide a summary and highlights of our progress in 2022.

GSK Dna And Tech Image

Our position on

Learn more about our views and our practices across a range of access, R&D, intellectual property, health security and environment issues here.

Policy positions

ESG reports archive

Search our archive of responsible business reports and resources dating back to 2002.

 

ESG Reports Archive

ESG ratings performance 

Detailed below is how we perform in key ESG ratings.

External benchmarking Current rating
Previous rating
Comments
S&P Global's Corporate Sustainability Assessment 84 86 1st in the pharmaceutical industry group; Assessment conducted annually, current score updated Nov 2023
Access to Medicines Index 4.06 4.23  Led the bi-annual index since its inception in 2008; Updated bi-annually, current results from Nov 2022
Antimicrobial Resistance Benchmark 84% 86% Led the bi-annual benchmark since its inception in 2018; Current ranking updated Nov 2021
CDP Climate change A- A- Updated annually, current scores updated Feb 2024 (for supplier engagement, March 2023)
CDP Water security A- B Updated annually, current scores updated Feb 2024 (for supplier engagement, March 2023)
CDP Forests (palm oil) B A- Updated annually, current scores updated Feb 2024 (for supplier engagement, March 2023) 
CDP Forests (timber) B B Updated annually, current scores updated Feb 2024 (for supplier engagement, March 2023)
CDP Supplier engagement rating Leader Leader Updated annually, current scores updated Dec 2022 (for supplier engagement, March 2023)
Sustainalytics 16.7 18.6 1st percentile in pharma subindustry group; Lower score represents lower risk. Current ranking updated September 2023
MSCI AA AA Last rating action date: September 2023
Moody's ESG solutions 62 61 2nd in the pharmaceutical sector; Current score updated August 2023
ISS Corporate Rating B+ B+ Current score updated June 2023
FTSE4Good Member  Member  Member since 2004, latest review in June 2023
ShareAction’s Workforce Disclosure Initiative  79% 77% Current score updated Jan 2024

Updated January 2024​

Disclosure


We publish our charitable giving data in our Annual Report and ESG performance summary each year. We are further increasing transparency by publishing details of our individual charitable grants over £10,000 ($15,000). Details of the grants are available in the Charitable Grants report 2022 (PDF 417.1KB).

In addition to the grants of £10,000 or more declared here, GSK discloses grants to US-based non-profit organisations that foster increased understanding of scientific, clinical, and healthcare issues and contribute to improving patient care.

 

Back to top

GSK is a member of many trade and industry associations that primarily represent pharmaceutical, consumer products and vaccine businesses at the national, regional and international levels. 

Trade Association Membership 2022 (PDF - 100.8KB)
Back to top

Non-profit organisations founded by patients, care-givers, family members and health professionals are important stakeholders for GSK. 
 
They engage with healthcare providers, governments, the media, and patients to promote improved treatment and services for patients. They also campaign on issues that affect patients’ and care-givers’ lives, including increasing access to quality medicines, services and information on disease. Some carry out research into the causes of and potential treatments for specific conditions.
 
We support patient organisations across the globe and details of this funding are provided in PDF or by linking you to further information on a market's local website.

 

Global

Global Allergy and Asthma Patient Platform (GAAPP) (PDF-195KB)

International Alliance of Patient Organisations (IAPO) (PDF-456KB)

International Gynecologic Cancer Society (IGCS) (PDF-258KB)

Meningitis Research Foundation (MRF) (PDF-203KB)

World Hepatitis Alliance (WHA) (PDF-392KB)

World Ovarian Cancer Coalition (WOOC) (PDF-219KB)

 

UK

Asthma & Lung UK (PDF-43KB)

Blood Cancer (PDF-702KB)

Cancer 52 (PDF-62KB)

Eve Appeal (PDF-44KB)

Go Girls (PDF-24KB)

Kidney Care UK (PDF-43KB)

Kidney Wales Foundation (PDF-43KB)

Myeloma UK (PDF-44KB)

National Kidney Federation (PDF-44KB)

National Voices (PDF-24KB)

Ovacome (PDF-45KB)

Ovarian Cancer Action (PDF-43KB)

Patient Association (PDF-43KB)

PBC Foundation (PDF-66KB)

Peaches (PDF-24KB)

Shine Cancer Support (PDF-24KB)

Target Ovarian Cancer (PDF-24KB)

The Polycystic Kidney Disease Charity (PDF-24KB)

 

PAG disclosure 2021 (PDF-196KB)

PAG disclosure 2020 (PDF-627KB)

 

GSK also provides funding to support UK community healthcare charities through the GSK IMPACT Awards, in partnership with The King’s Fund. This annual programme recognises and promotes excellence in community healthcare, providing funding and training to help strengthen the award winners’ current management plans and support their future aspirations. 

BHA for Equality in Health Social Care (PDF-23KB)

Dads Unlimited (PDF-23KB)

Dementia Forward (PDF-23KB)

Mancroft Advice Project (PDF-23KB)

Mulberry Centre (PDF-23KB)

The Brigstowe Project (PDF-23KB)

The Lowdown (PDF-23KB)

Trekstock (PDF-23KB)

 

Americas

Brazil 

Canada

Colombia (PDF-201KB)

 

Asia Pacific

Australia

Hong Kong (PDF-654KB)

New Zealand (PDF-114KB)

South Korea

Taiwan (PDF-394KB)

 

Europe

Europa Donna (198KB)

European Cancer Patient Coalition (ECPC) (PDF-206KB)

European Federation of Allergy and Airways Disease Patients Association (PDF-197KB)

European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) (PDF-206KB)

European Patients' Forum (PDF-272)

Lupus Europe (PDF-339KB)

Myeloma Patients Europe (PDF-246KB)

Sarcoma Patients EuroNet (SPAEN) (PDF-343KB)

 

Austria (PDF-84KB)

BeLux (PDF-206KB)

Bulgaria (PDF-393KB)

Croatia (PDF-95KB)

Czech Republic 

Denmark 

Finland

France 

Germany

Greece

Hungary (PDF-92KB)

Ireland (PDF-100KB)

Israel (212KB)

Italy

Latvia (PDF-163KB)

Lithuania (PDF-117KB)

The Netherlands (PDF-406KB)

Norway (PDF-171KB)

Poland

Portugal 

Romania (PDF-84KB)

Serbia (PDF-121KB)

Slovakia (PDF-85KB)

Slovenia (PDF-136KB)

Spain

Sweden (PDF-288KB)

Switzerland

Turkey

 

Back to top

We are committed to disclosing the payments we make, as we work together with healthcare professionals. Find our disclosure reports at Engaging with healthcare professionals.

Back to top